Correlation Between SAB Biotherapeutics and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and MAIA Biotechnology, you can compare the effects of market volatilities on SAB Biotherapeutics and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and MAIA Biotechnology.
Diversification Opportunities for SAB Biotherapeutics and MAIA Biotechnology
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and MAIA is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and MAIA Biotechnology
Given the investment horizon of 90 days SAB Biotherapeutics is expected to generate 1.31 times more return on investment than MAIA Biotechnology. However, SAB Biotherapeutics is 1.31 times more volatile than MAIA Biotechnology. It trades about 0.02 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about 0.01 per unit of risk. If you would invest 650.00 in SAB Biotherapeutics on September 24, 2024 and sell it today you would lose (185.00) from holding SAB Biotherapeutics or give up 28.46% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 99.8% |
Values | Daily Returns |
SAB Biotherapeutics vs. MAIA Biotechnology
Performance |
Timeline |
SAB Biotherapeutics |
MAIA Biotechnology |
SAB Biotherapeutics and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SAB Biotherapeutics and MAIA Biotechnology
The main advantage of trading using opposite SAB Biotherapeutics and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
MAIA Biotechnology vs. Fate Therapeutics | MAIA Biotechnology vs. Sana Biotechnology | MAIA Biotechnology vs. Caribou Biosciences | MAIA Biotechnology vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |